Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy

Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy

Bibliographic Details
Main Authors:	Saeid Latifi-Navid, Reza Safaralizadeh, Lixuan Wei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	ctDNA cancer therapy response monitoring biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1210866/full

Similar Items

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
by: Estela Sánchez-Herrero, et al.
Published: (2022-07-01)

Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages
by: Brittany A. McKelvey, et al.
Published: (2024-04-01)

The Clinical Utility of Circulating HPV DNA Biomarker in Oropharyngeal, Cervical, Anal, and Skin HPV-Related Cancers: A Review
by: Ioana Maria Andrioaie, et al.
Published: (2023-07-01)

Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
by: Lemei Zhu, et al.
Published: (2023-08-01)

Circulating tumor DNA kinetics: A future tool for radiation therapy personalization in lung cancer?
by: Gerard M. Walls, et al.
Published: (2024-12-01)

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation
by: Edmond M. Kwan, et al.
Published: (2022-11-01)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
by: Andrew A. Davis, et al.
Published: (2019-12-01)

Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker
by: Li Li, et al.
Published: (2023-12-01)

Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab
by: Maya Kansara, et al.
Published: (2023-02-01)

Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non‐Small Cell Lung Cancer Treated With Microwave Ablation
by: Lin Cheng, et al.
Published: (2025-01-01)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
by: Gui‐Qi Zhu, et al.
Published: (2022-01-01)

Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring
by: Ga Young Moon, et al.
Published: (2025-01-01)

Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients
by: Valerio Gristina, et al.
Published: (2024-09-01)

Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
by: Jiaping Li, et al.
Published: (2020-08-01)

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments
by: Youjin Oh, et al.
Published: (2024-05-01)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
by: Jin Ju Kim, et al.
Published: (2023-02-01)

Dynamics of cell-free tumor DNA correlate with early MRI response during chemoradiotherapy in rectal cancer
by: Kerstin Clasen, et al.
Published: (2024-11-01)

Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2023-12-01)

Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study
by: Arnaud Bayle, et al.
Published: (2023-11-01)

Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients
by: Mandy Radefeldt, et al.
Published: (2023-11-01)

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
by: Mifanwy Reece, et al.
Published: (2019-11-01)

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
by: Zongbi Yi, et al.
Published: (2019-05-01)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
by: Russell J Diefenbach, et al.
Published: (2020-09-01)

Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report
by: Tapas Ranjan Behera, et al.
Published: (2022-06-01)

Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study
by: Rui Fu, et al.
Published: (2023-05-01)

Cervical Cancer Genetic Profile through Circulating Tumor DNA: What Can We Learn from Blood?
by: Sevastiani Antonouli, et al.
Published: (2024-07-01)

Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR
by: Duhita Mirikar, et al.
Published: (2025-01-01)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
by: Xiaoxu Fang, et al.
Published: (2022-10-01)

Circulating tumor DNA – A potential aid in the management of chordomas
by: Stephen C. Frederico, et al.
Published: (2022-10-01)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
by: Shu‐Qiang Yuan, et al.
Published: (2023-12-01)

The Specific Gravity-Free Method for the Isolation of Circulating Tumor KRAS Mutant DNA and Exosome in Colorectal Cancer
by: Tae Hee Lee, et al.
Published: (2021-08-01)

Genome-wide methylation analysis of circulating tumor DNA: A new biomarker for recurrent glioblastom
by: Lin Dai, et al.
Published: (2023-03-01)

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01)

Bibliometric analysis of global research trends and prospects on circulating tumor DNA in colorectal cancer
by: Jing Pang, et al.
Published: (2024-11-01)

Liquid biopsy: Cell-free DNA based analysis in breast cancer
by: Konstantinos Venetis, et al.
Published: (2023-09-01)

Methodology established for the detection of circulating tumor DNA by hybridization capture
by: Xumei Yao, et al.
Published: (2022-09-01)

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling
by: Zhanhong Chen, et al.
Published: (2020-02-01)

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
by: Xiaoling Wang, et al.
Published: (2024-01-01)

Genomic characterization of metastatic patterns in prostate cancer using circulating tumor DNA data from the SCRUM-Japan MONSTAR SCREEN project
by: Masaki Shiota, et al.
Published: (2025-03-01)

Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC
by: Xiya Ma, et al.
Published: (2023-07-01)